Co-Diagnostics Inc. CODX on Wednesday said CoSara Diagnostics Pvt. Ltd, its joint venture in India, is initiating clinical ...
The prepared remarks did not provide EPS or revenue guidance for 2026. Egan said the company is “planning to pursue an initial regulatory submission focused on flu A, flu B and RSV,” positioning the ...
(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results